BioSpace News Archive

Anova Enterprises, Inc. (Anova) today announced a partnership with the Mary Crowley Cancer Research (Mary Crowley) to establish and support a technology enabled approach to extend early Phase clinical trials to cancer patients in the Southern and Southwestern United States.

ELEVAI LABS, INC., a science-based, data-driven regenerative aesthetic skincare company is pleased to announce it has completed the expansion of their Davis, California laboratory and office space to accommodate the recent growth in sales and the near-term product line expansion.

Mission Bio, Inc. announced the first findings by researchers using its new Tapestri® Single-cell Multi-omics Measurable Residual Disease assay, as researchers from Memorial Sloan Kettering Cancer Center discovered subclonal co-mutations and immunophenotypic profiles that can distinguish individual cells indicative of future acute myeloid leukemia relapse from others present after treatment.

The National Safety Council, the nation’s leading workplace safety advocate, released Friday a new report finding that 50% of large employers (250+ employees) have observed an increase in mental health or impairment-related absences and incidents during the pandemic.

Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration’s (“FDA”) Oncologic Drugs Advisory Committee (“ODAC”) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer (“NSCLC”) harboring HER2 exon 20 insertion mutations.

Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that the company will participate in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on Thursday, September 29, 2022, at 10:15 a.m. ET.

Maxwell Biosciences to Present Data on CLAROMER TM Platform’s Treatment and Prevention of SARS-CoV-2 and Other Respiratory Viruses at OPTIONS XI Conference.

PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection.

Vericel Corporation today announced that Chief Financial Officer Joe Mara will present at the upcoming Ladenburg Thalmann Healthcare Conference.

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company developing novel bile acid modulators to treat pediatric and adult liver diseases, entered into a royalty monetization agreement with Sagard Healthcare Partners (“Sagard”) for a total of $115 million upfront in return for a mid-single digit average royalty rate on Bylvay global annual net revenues.